Sign In

Melinda Griffith

Senior Executive/Board Member

Melinda Griffith is a senior executive with a rich background in leading business development, licensing, risk management, and legal activities in therapeutic, diagnostic, and device companies.

She specializes in evaluating and acquiring novel immunotherapies, technologies, and biomarkers in cancer and infectious diseases.

Melinda was instrumental in managing PCR technology outlicensing programs, resulting in over 300 licensees and generating significant annual royalty revenue for Hoffmann LaRoche.

She also played a key role in directing lobbying efforts for GE Healthcare to address CMS coverage and reimbursement concerns related to in vitro diagnostic tests.

Melinda Griffith holds a Juris Doctor (J.D.) from the University of California, Hastings College of the Law and a B.S. from the University of California, Berkeley - Walter A. Haas School of Business.

She is actively involved in several organizations, including serving as the Chair of the Compensation Committee on the Board of Directors at OncoCyte Corporation (OCX NYSE American).

M
Add to my network

Location

Oakland, California, United States